A detailed history of Advisor Group Holdings, Inc. transactions in Surmodics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 64 shares of SRDX stock, worth $2,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64
Previous 164 60.98%
Holding current value
$2,529
Previous $6,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$38.47 - $42.24 $3,847 - $4,224
-100 Reduced 60.98%
64 $2,000
Q2 2024

Aug 13, 2024

SELL
$25.39 - $42.1 $12,695 - $21,050
-500 Reduced 75.3%
164 $6,000
Q1 2024

May 10, 2024

BUY
$27.44 - $35.56 $9,329 - $12,090
340 Added 104.94%
664 $19,000
Q4 2023

Feb 12, 2024

SELL
$28.47 - $38.49 $4,242 - $5,735
-149 Reduced 31.5%
324 $11,000
Q3 2023

Nov 13, 2023

BUY
$28.28 - $38.36 $8,370 - $11,354
296 Added 167.23%
473 $15,000
Q2 2023

Aug 10, 2023

SELL
$17.67 - $31.31 $618 - $1,095
-35 Reduced 16.51%
177 $5,000
Q1 2023

May 12, 2023

BUY
$17.13 - $38.52 $222 - $500
13 Added 6.53%
212 $4,000
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $144 - $194
-5 Reduced 2.45%
199 $6,000
Q1 2022

May 04, 2022

BUY
$40.68 - $49.72 $4,068 - $4,972
100 Added 96.15%
204 $10,000
Q3 2021

Nov 05, 2021

BUY
$52.8 - $60.32 $264 - $301
5 Added 5.05%
104 $6,000
Q4 2020

Feb 10, 2021

SELL
$35.18 - $43.52 $3,518 - $4,352
-100 Reduced 50.25%
99 $4,000
Q3 2020

Nov 12, 2020

SELL
$37.98 - $48.72 $15,191 - $19,488
-400 Reduced 66.78%
199 $8,000
Q2 2020

Aug 14, 2020

BUY
$31.07 - $44.74 $11,744 - $16,911
378 Added 171.04%
599 $26,000
Q1 2020

May 18, 2020

BUY
$22.46 - $42.24 $4,963 - $9,335
221 New
221 $7,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $553M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.